DNA Topoisomerases in Cancer Therapy

Present and Future

Nonfiction, Science & Nature, Science, Biological Sciences, Biochemistry, Health & Well Being, Medical, Specialties, Oncology
Cover of the book DNA Topoisomerases in Cancer Therapy by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461501411
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461501411
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer drugs in mammals and in the yeast Saccharomyces cerevisiae, which has proved to be a superb model organism for studies of anticancer drugs. This volume compiles up-to-date information on the topoisomerase-targeting compounds in clinical and preclinical development as a useful and important reference book for students and researchers in the field of pharmacology, toxicology, oncology and molecular biology.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer drugs in mammals and in the yeast Saccharomyces cerevisiae, which has proved to be a superb model organism for studies of anticancer drugs. This volume compiles up-to-date information on the topoisomerase-targeting compounds in clinical and preclinical development as a useful and important reference book for students and researchers in the field of pharmacology, toxicology, oncology and molecular biology.

More books from Springer US

Cover of the book The Neuropsychology of Language by
Cover of the book Communication Disorders and Personality by
Cover of the book Wave Pipelining: Theory and CMOS Implementation by
Cover of the book Ultrasound in Medicine by
Cover of the book Current Hypotheses and Research Milestones in Alzheimer's Disease by
Cover of the book Excitatory-Inhibitory Balance by
Cover of the book Basic, Clinical, and Surgical Nephrology by
Cover of the book Infectious Complications of Cancer by
Cover of the book Speech Processing in Embedded Systems by
Cover of the book Painting and Our Inner World by
Cover of the book Clinical Evaluation of Antitumor Therapy by
Cover of the book Theileria by
Cover of the book Handbook of Social Network Technologies and Applications by
Cover of the book Health Education by
Cover of the book Nocturnal Non-Invasive Ventilation by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy